Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice

被引:189
作者
Li, Yinghui [1 ,2 ]
Kundu, Parag [1 ,3 ]
Seow, Shih Wee [4 ]
de Matos, Cristina Teixeira [1 ]
Aronsson, Linda [1 ]
Chin, Keh Chuang [2 ]
Karre, Klas [1 ]
Pettersson, Sven [1 ,3 ,4 ]
Greicius, Gediminas [4 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-11777 Stockholm, Sweden
[2] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore
[3] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore
[4] Natl Canc Ctr, Singapore 169610, Singapore
关键词
PROMOTES COLON TUMORIGENESIS; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; ACTIVATED MACROPHAGES; SIGNALING PATHWAY; SUPPRESSOR-CELLS; ERYTHROID-CELLS; BREAST-CANCER; MOUSE MODEL; ERYTHROPOIETIN;
D O I
10.1093/carcin/bgs137
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Chronic inflammation is increasingly recognized as a major contributor of human colorectal cancer (CRC). While gut microbiota can trigger inflammation in the intestinal tract, the precise signaling pathways through which host cells respond to inflammatory bacterial stimulation are unclear. Here, we show that gut microbiota enhances intestinal tumor load in the APC(Min/+) mouse model of CRC. Furthermore, systemic anemia occurs coincident with rapid tumor growth, suggesting a role for intestinal barrier damage and erythropoiesis-stimulating mitogens. Short-term stimulation assays of murine colonic tumor cells reveal that lipopolysaccharide, a microbial cell wall component, can accelerate cell growth via a c-Jun/INK activation pathway. Colonic tumors are also infiltrated by CD11b+ myeloid cells expressing high levels of phospho-STAT3 (p-Tyr705). Our results implicate the role of gut microbiota, through triggering the c-Jun/JNK and STAT3 signaling pathways in combination with anemia, in the acceleration of tumor growth in APC(Min/+) mice.
引用
收藏
页码:1231 / 1238
页数:8
相关论文
共 45 条
[1]
Signaling molecules: The pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer [J].
Atreya, R. ;
Neurath, M. F. .
CURRENT DRUG TARGETS, 2008, 9 (05) :369-374
[2]
BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription [J].
Brocke-Heidrich, K. ;
Ge, B. ;
Cvijic, H. ;
Pfeifer, G. ;
Loeffler, D. ;
Henze, C. ;
McKeithan, T. W. ;
Horn, F. .
ONCOGENE, 2006, 25 (55) :7297-7304
[3]
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression [J].
Bunt, SK ;
Sinha, P ;
Clements, VK ;
Leips, J ;
Ostrand-Rosenberg, S .
JOURNAL OF IMMUNOLOGY, 2006, 176 (01) :284-290
[4]
Bc13-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer [J].
Choi, Hee June ;
Lee, Ji Min ;
Kim, Hyunkyung ;
Nam, Hye Jin ;
Shin, Hi-Jai R. ;
Kim, Dongha ;
Ko, Enyoung ;
Noh, Dong-Young ;
Kim, Keun Il ;
Kim, Jung Hwa ;
Baek, Sung Hee .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 400 (03) :396-402
[5]
Carcinogenesis of Helicobacter pylori [J].
Correa, Pelayo ;
Houghton, Jeanmarie .
GASTROENTEROLOGY, 2007, 133 (02) :659-672
[6]
A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis [J].
Deng, Lin ;
Zhou, Jin-Feng ;
Sellers, Rani S. ;
Li, Jiu-Feng ;
Nguyen, Andrew V. ;
Wang, Yubao ;
Orlofsky, Amos ;
Liu, Qiang ;
Hume, David A. ;
Pollard, Jeffrey W. ;
Augenlicht, Leonard ;
Lin, Elaine Y. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (02) :952-967
[7]
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review [J].
Desai, J ;
Demetri, GD .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (03) :389-406
[8]
Dove WF, 1997, CANCER RES, V57, P812
[9]
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota [J].
Elson, CO ;
Cong, Y ;
McCracken, VJ ;
Dimmitt, RA ;
Lorenz, RG ;
Weaver, CT .
IMMUNOLOGICAL REVIEWS, 2005, 206 :260-276
[10]
The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease [J].
Ewaschuk J.B. ;
Tejpar Q.Z. ;
Soo I. ;
Madsen K.L. ;
Fedorak R.N. .
Current Gastroenterology Reports, 2006, 8 (6) :486-498